Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis
Henning W. Zimmermann(Sankt-Antonius-Hospital Eschweiler), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum), Alma Zernecke(Universitätsklinikum Würzburg), Jacob Nattermann(University Hospital Bonn), Ralf Weiskirchen(Universitätsklinikum Aachen), Claus Hellerbrand(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sebastian Seidler(Universitätsklinikum Aachen), Tom Luedde(Düsseldorf University Hospital), Jens J. W. Tischendorf(Universitätsklinikum Aachen), Nikolaus Gaßler(Ernst Abbe University of Applied Sciences Jena)
Cited by 311
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k